Deutsche Bank’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $161K | Hold |
40,215
| – | – | ﹤0.01% | 3052 |
|
|
2025
Q1 | $36.6K | Hold |
40,215
| – | – | ﹤0.01% | 3393 |
|
|
2024
Q4 | $111K | Buy |
40,215
+9,055
| +29% | +$25.1K | ﹤0.01% | 3222 |
|
|
2024
Q3 | $163K | Buy |
31,160
+13,461
| +76% | +$70.4K | ﹤0.01% | 2976 |
|
|
2024
Q2 | $78.9K | Buy |
17,699
+2,284
| +15% | +$10.2K | ﹤0.01% | 3151 |
|
|
2024
Q1 | $118K | Sell |
15,415
-819
| -5% | -$6.27K | ﹤0.01% | 3052 |
|
|
2023
Q4 | $69.2K | Hold |
16,234
| – | – | ﹤0.01% | 3320 |
|
|
2023
Q3 | $68.2K | Buy |
+16,234
| New | +$68.2K | ﹤0.01% | 3302 |
|
|
2022
Q2 | – | Sell |
-7,810
| Closed | -$32K | – | 4037 |
|
|
2022
Q1 | $32K | Sell |
7,810
-918
| -11% | -$3.76K | ﹤0.01% | 3852 |
|
|
2021
Q4 | $60K | Buy |
8,728
+452
| +5% | +$3.11K | ﹤0.01% | 3796 |
|
|
2021
Q3 | $96K | Sell |
8,276
-266
| -3% | -$3.09K | ﹤0.01% | 3845 |
|
|
2021
Q2 | $146K | Buy |
8,542
+609
| +8% | +$10.4K | ﹤0.01% | 3904 |
|
|
2021
Q1 | $157K | Buy |
7,933
+1,787
| +29% | +$35.4K | ﹤0.01% | 3719 |
|
|
2020
Q4 | $127K | Buy |
6,146
+1,716
| +39% | +$35.5K | ﹤0.01% | 3644 |
|
|
2020
Q3 | $116K | Buy |
+4,430
| New | +$116K | ﹤0.01% | 3429 |
|